Mycobacterium Chelonae Developing Multidrug Resistance

BMJ Case Reports
Vinod Kumar MannelliNaga Preethi Kadiri

Abstract

Mycobacterium chelonae is a rapidly growing mycobacterium which is known to respond well to standard antibiotic treatment regimen. There are no specific guidelines for treatment. Antibiotics are chosen based on the bacterial sensitivity. Here we present a 47-year-old man with hip replacement who developed bright red papular generalised skin lesions and bilateral hip abscess. On workup, it was confirmed that M. chelonae was the causative organism. He was given 8 weeks of antibiotics; however, there was worsening of the hip abscess on interval imaging. The progression was most likely due to M. chelonae developing antibiotic resistance. Physicians should be aware of the rising resistance of this organism, and guide antibiotic therapy based on bacterial sensitivity to yield better outcomes.

References

Jul 1, 1993·International Journal of Dermatology·D A RotmanF A Kerdel
Jun 1, 1993·Molecular Microbiology·H NikaidoE Y Rosenberg
Dec 26, 1996·The New England Journal of Medicine·M J NewportM Levin
Apr 28, 2000·Cancer Control : Journal of the Moffitt Cancer Center·C L KaneR L Sandin
Aug 21, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S R HaasR A Duncan
Oct 5, 2002·Clinical Microbiology Reviews·Barbara A Brown-Elliott, Richard J Wallace
Aug 7, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cécile VignalElisabeth Elass
Nov 16, 2004·The British Journal of Dermatology·S D Kyle, W M Porter
Feb 6, 2007·American Journal of Respiratory and Critical Care Medicine·David E GriffithUNKNOWN Infectious Disease Society of America
Aug 23, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Albert J EidRaymund R Razonable
Mar 12, 2009·Current Opinion in Infectious Diseases·Rod J Hay
Oct 29, 2009·Emerging Infectious Diseases·Kevin L WinthropPhilip A LoBue
May 27, 2010·Clinical and Experimental Dermatology·J HalpernB B Tan
Jul 1, 2010·Emerging Infectious Diseases·Moon J Kim, Laurene Mascola
Oct 28, 2010·BMJ : British Medical Journal·Joana GoldmanPascal Joly
Sep 6, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Yan SongJianghua Chen
Sep 10, 2011·Clinical & Experimental Ophthalmology·Dalia O GirgisDarlene Miller
Jan 14, 2012·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Anna SajdudaJuan Carlos Palomino
Apr 21, 2012·Survey of Ophthalmology·Ramana S MoorthyNarsing A Rao
Aug 24, 2012·The New England Journal of Medicine·Byron S KennedyMark H Goldgeier
Feb 27, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M KuninE J Holtzman
Sep 10, 2015·Case Reports in Dermatology·Miguel Pinto-GouveiaAmérico Figueiredo
Mar 24, 2017·The Journal of Antimicrobial Chemotherapy·Faiza MougariUNKNOWN French National Reference Center for Mycobacteria

❮ Previous
Next ❯

Citations

Nov 2, 2019·Clinical and Experimental Dermatology·M GibsonB S Daniel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The Journal of Infection
R HeathcockM D Yates
Disease-a-month : DM
Robin B McFee
Bulletin of the International Union Against Tuberculosis and Lung Disease
R de HallerT Kobel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
D Pandita, P J Carson
© 2022 Meta ULC. All rights reserved